Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
33rd NZW-Hamburg33rd NZW-Hamburg
Not Confirmed
Not Confirmed
07-09 February, 2025
RNA TherapeuticsRNA Therapeutics
Not Confirmed
Not Confirmed
10-11 February, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
33rd NZW-Hamburg33rd NZW-Hamburg
Industry Trade Show
Not Confirmed
07-09 February, 2025
RNA TherapeuticsRNA Therapeutics
Industry Trade Show
Not Confirmed
10-11 February, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-okays-50-new-drugs-in-2024-bms-cobenfy-lilly-s-kisunla-lead-pack-of-breakthrough-therapies
25 Jan 2025
// ENDPTS
https://endpts.com/boehringer-merges-cancer-vaccine-and-oncolytic-virus-teams-dantari-sells-off-assets/
16 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/16/3010915/0/en/Boehringer-provides-update-on-iclepertin-Phase-III-program-in-schizophrenia.html
10 Jan 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/lonzas-synaffix-adds-boehringer-ingelheim-its-constellation-partners-1b-adc-technology-pact
09 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/09/3007026/0/en/Boehringer-Ingelheim-Acquires-Fourth-License-for-the-Development-of-Novel-Antibody-Based-Cancer-Treatments-from-Oxford-BioTherapeutics.html
07 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/07/3005524/0/en/Sutro-Biopharma-and-Boehringer-Ingelheim-BioXcellence-collaboration-Established-first-in-class-cell-free-capabilities-at-commercial-scale.html
13 Dec 2024
// BIOSPECTRUM
https://www.biospectrumasia.com/news/25/25326/malaysia-gives-nod-to-boehringer-ingelheims-spesolimab-for-treatment-of-generalised-pustular-psoriasis-flares-in-adults.html
Inspections and registrations